DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Capital Market: DBVT) (the "Company”), a late-stage biopharmaceutical company, today announced that it has filed a new automatically ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results